Moreover, in peritoneal mesothelioma cells, the combined treatment with GLUT-1 and LDH-A inhibitors significantly reduced the nucleotide pool, giving new options for further study and anticancer treatments. Here, SLC2A1 is linked to peritoneal mesothelioma.